SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently seeing high investor interest fueled by a combination of positive clinical data and favorable regulatory tailwinds, including a rolling FDA review and a new priority designation for their psilocybin-based depression therapy. The community is actively discussing the stock's potential for a significant re-rating, with many focusing on the upcoming durability trial data, the company's strong cash position, and growing institutional confidence in the sector.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors weigh an upbeat delivery report and raised production guidance against the dilution concerns of a significant public share offering. While some participants express frustration over the timing of the capital raise, the community is actively debating the stock's future liquidity, the strategic funding of factory expansion, and the long-term potential of the upcoming R2 vehicle line.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing heavy selling pressure as semiconductor stocks undergo a sharp rotation, with investors debating whether the current decline represents a temporary pullback in the AI growth narrative or a structural shift in the sector. Community sentiment is deeply divided, with many traders aggressively scaling into the dip to capitalize on anticipated rebounds, while others warn of further downside and decaying leverage risks as market participants brace for upcoming economic data.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is attracting heavy attention as the company directly refuted reports of a multi-year delay to its next-generation Kyber AI architecture, reinforcing its growth roadmap to investors. While community discussions highlight volatility driven by broader concerns over AI capital expenditure and competitive chip developments, many traders are focusing on the stock's consolidation near key technical support levels as a potential base for a bullish reversal.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending following a massive $10 billion acquisition by Vertex Pharmaceuticals, with shares rallying significantly as the market digests the all-cash deal. Community discussion is focused on the premium valuation, the successful exit for long-term holders, and speculation regarding which rare-disease biotech might be the next target for similar big pharma consolidation.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly Aerospace is gaining traction as investors focus on its recent 13 million dollar NASA JPL subcontract for a Mars aeroshell mission, which highlights the company's growing role in cislunar infrastructure. While some community members are frustrated by recent price volatility and sector-wide liquidity shifts, many remain bullish on the long-term potential of the firm's expanding defense and lunar contract backlog.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant volatility following the completion of its Alkira acquisition, which aims to integrate software-defined networking into its AI-focused fiber infrastructure. While management positions this as a strategic pivot toward higher-margin software services, investors are actively debating whether this heavy capital expenditure strategy will deliver on promised revenue inflection points or continue to burden the balance sheet.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions ($PENG) is rallying as investors gain confidence in its role as a specialized AI infrastructure integrator, following its recent designation as an NVIDIA AI Factory partner and the appointment of key leadership with deep industry connections. Community sentiment is heavily focused on the stock's potential for a valuation re-rating, with discussions highlighting its exposure to high-growth memory segments and its direct collaboration with major enterprise technology partners.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is in focus following a definitive $10 billion agreement to acquire Crinetics Pharmaceuticals, a strategic move that expands its rare disease pipeline into the endocrinology sector with promising late-stage assets. Investors are actively debating the 100% acquisition premium and Vertex's long-term strategy, while technical analysts highlight the stock's potential for a rally as it strengthens its market position.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending as investors weigh strong earnings and guidance against a significant workforce reduction tied to a pivot toward an agentic AI-first operating model. The community is intensely debating whether these layoffs indicate a structural transformation that will drive long-term margin expansion or if the market is overreacting to cost-cutting measures during a period of high valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Eldorado Gold Stock Was Diving This Week

Key PointsInterest rate hikes in the U.S. are becoming a real possibility, according to some professional Fed-watchers...

Gold Tumbles From Record HighsBut These Gold Miners Are Climbing Into Top Momentum Zones

Gold pulls back from record highs, but SSR Mining, Centerra Gold and Eldorado Gold climb Benzinga Edge momentum rankings.read more...

EGO Reaches Milestone With First Copper Concentrate at McIlvenna Bay 

Eldorado Gold produced its first copper concentrate at McIlvenna Bay, reaching a milestone as the project expands copper exposure and growth plans.

New Strong Sell Stocks for June 2nd

APOG, BIDU and EGO have been added to the Zacks Rank #5 (Strong Sell) List on June 2nd, 2026.

Eldorado Gold (TSE:ELD) Insider Buys C$498,108.00 in Stock

Eldorado Gold Co. (TSE:ELD - Get Free Report) (NYSE:EGO) insider Christian Milau purchased 12,400 shares of Eldorado Gold stock in a transaction that occurred on Tuesday, May 5th. The stock was...

Insider Buying: Eldorado Gold (TSE:ELD) Director Buys 6,000 Shares of Stock

Eldorado Gold Co. (TSE:ELD - Get Free Report) (NYSE:EGO) Director Steven Paul Reid bought 6,000 shares of the firm's stock in a transaction on Wednesday, May 6th. The shares were purchased at an...

Insider Buying: Eldorado Gold (TSE:ELD) Director Acquires 1,240 Shares of Stock

Eldorado Gold Co. (TSE:ELD - Get Free Report) (NYSE:EGO) Director Sally Louise Eyre acquired 1,240 shares of Eldorado Gold stock in a transaction dated Tuesday, May 5th. The shares were bought at an...

Eldorado Gold (TSE:ELD) Insider Paul Anthony Ferneyhough Acquires 1,100 Shares

Eldorado Gold Co. (TSE:ELD - Get Free Report) (NYSE:EGO) insider Paul Anthony Ferneyhough acquired 1,100 shares of the firm's stock in a transaction on Wednesday, May 6th. The shares were acquired at...

Stephen David Walker Purchases 1,000 Shares of Eldorado Gold (TSE:ELD) Stock

Eldorado Gold Co. (TSE:ELD - Get Free Report) (NYSE:EGO) Director Stephen David Walker bought 1,000 shares of the stock in a transaction on Tuesday, May 5th. The stock was acquired at an average...

Eldorado Gold (NYSE:EGO) Rating Lowered to "Hold" at ATB Cormark Capital Markets

ATB Cormark Capital Markets cut shares of Eldorado Gold from a "moderate buy" rating to a "hold" rating in a report on Monday...

Eldorado Gold Corp. engages in the mining, development, and exploration of gold. It operates through the following segment: Turkey, Canada, and Greece. The company was founded by Richard J. Barclay, Marco Antonio Romero, and Gary D. Nordin on April 2, 1992 and is headquartered in Vancouver, Canada.

Eldorado Gold Corp.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$33.41
Prev Close	$33.68
Open	$34.20
Dividend Yield	0.00%
50-Day Moving Average	$31.85
Beta	0.85
Avg. Volume	3.12M
PE Ratio	11.74

52-Week High	$51.16
52-Week Low	$19.62
Market Capitalization	$8.72B
EPS (Annual)	$2.50
Price to Book	1.52
Revenue Per Employee	$227,186.61

Feed

News

Sentiment

Earnings

Fundamentals

Info

EGOEldorado Gold Corp.

Latest EGO News